Post job

Invagen Pharmaceuticals Inc.'s revenue is $1.0 million.

What is Invagen Pharmaceuticals Inc.'s revenue?

Invagen Pharmaceuticals Inc.'s annual revenue is $1.0M. Zippia's data science team found the following key financial metrics about Invagen Pharmaceuticals Inc. after extensive research and analysis.
  • Invagen Pharmaceuticals Inc. has 50 employees, and the revenue per employee ratio is $20,000.
  • Invagen Pharmaceuticals Inc. peak revenue was $1.0M in 2024.

On this page

Peak revenue
$1.0M (2025)
Company peak revenue
Revenue / employee
$20,000
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$1.0M (2025)
Company peak revenue
Revenue / employee
$20,000
Company revenue / employee

Invagen Pharmaceuticals Inc. competitors

Invagen Pharmaceuticals Inc.'s top competitor, Johnson Matthey Plc, earned an annual revenue of $18.1B.

Invagen Pharmaceuticals Inc.'s smallest competitor is Palatin Technologies with revenue of $4.9M last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
Bactolac Pharmaceutical-$150.0M100-
Johnson Matthey Plc-$18.1B14,000-
Ben Venue Laboratories Inc-$63.0M99-
Sandoz-$21.0M34-
Medefil-$20.6M65-
Palatin Technologies-$4.9M18-
Hydrite-$650.0M796-
Manhattan Drug-$43.7M100-
Biovest International-$8.0M125-
Aprecia Pharmaceuticals-$16.4M20-

Invagen Pharmaceuticals Inc. revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Invagen Pharmaceuticals Inc., including salaries, political affiliations, employee data, and more, in order to inform job seekers about Invagen Pharmaceuticals Inc.. The employee data is based on information from people who have self-reported their past or current employments at Invagen Pharmaceuticals Inc.. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Invagen Pharmaceuticals Inc.. The data presented on this page does not represent the view of Invagen Pharmaceuticals Inc. and its employees or that of Zippia.

Invagen Pharmaceuticals Inc. may also be known as or be related to Invagen Pharmaceuticals Inc. and Pharmajen Inc.